Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
OxLDL as an Inducer of a Metabolic Shift in Cancer Cells.
Bitorina AV, Oligschlaeger Y, Ding L, Yadati T, Westheim A, Houben T, Vaes RDW, Olde Damink SWM, Theys J, Shiri-Sverdlov R. Bitorina AV, et al. Among authors: oligschlaeger y. J Cancer. 2021 Aug 3;12(19):5817-5824. doi: 10.7150/jca.56307. eCollection 2021. J Cancer. 2021. PMID: 34475995 Free PMC article.
Low profile high value target: The role of OxLDL in cancer.
Bitorina AV, Oligschlaeger Y, Shiri-Sverdlov R, Theys J. Bitorina AV, et al. Among authors: oligschlaeger y. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Dec;1864(12):158518. doi: 10.1016/j.bbalip.2019.158518. Epub 2019 Aug 31. Biochim Biophys Acta Mol Cell Biol Lipids. 2019. PMID: 31479734 Free article. Review.
Myosteatosis in NAFLD patients correlates with plasma Cathepsin D.
Ding L, De Munck TJI, Oligschlaeger Y, Dos Reis IM, Verbeek J, Koek GH, Houben T, Shiri-Sverdlov R. Ding L, et al. Among authors: oligschlaeger y. Biomol Concepts. 2021 May 15;12(1):27-35. doi: 10.1515/bmc-2021-0004. Biomol Concepts. 2021. PMID: 33991468 Free article.
Inhibition of Extracellular Cathepsin D Reduces Hepatic Lipid Accumulation and Leads to Mild Changes in Inflammationin NASH Mice.
Yadati T, Houben T, Bitorina A, Oligschlaeger Y, Gijbels MJ, Mohren R, Lütjohann D, Khurana P, Goyal S, Kulkarni A, Theys J, Cillero-Pastor B, Shiri-Sverdlov R. Yadati T, et al. Among authors: oligschlaeger y. Front Immunol. 2021 Jul 16;12:675535. doi: 10.3389/fimmu.2021.675535. eCollection 2021. Front Immunol. 2021. PMID: 34335574 Free PMC article.
Nonalcoholic Fatty Liver Disease.
Ding L, Oligschlaeger Y, Shiri-Sverdlov R, Houben T. Ding L, et al. Among authors: oligschlaeger y. Handb Exp Pharmacol. 2022;270:233-269. doi: 10.1007/164_2020_352. Handb Exp Pharmacol. 2022. PMID: 32185502 Review.
Macrophage Stimulating Protein Enhances Hepatic Inflammation in a NASH Model.
Li J, Chanda D, van Gorp PJ, Jeurissen ML, Houben T, Walenbergh SM, Debets J, Oligschlaeger Y, Gijbels MJ, Neumann D, Shiri-Sverdlov R. Li J, et al. Among authors: oligschlaeger y. PLoS One. 2016 Sep 29;11(9):e0163843. doi: 10.1371/journal.pone.0163843. eCollection 2016. PLoS One. 2016. PMID: 27685150 Free PMC article.
29 results